Alliance Bio-Products files 506(c)

Bio-Products' 506c offering will allow the company to sell 1 000 000 shares of its securities to accredited investors. The company will offer 8% convertible preferred stock at US$10 per share, with a preferred minimum investment of US$5000. The offering will be conducted on a best efforts basis through the company's website, where the Private Placement Memorandum and Accredited Investor Questionnaire are located.

Bio-Products has made an offer to purchase an 8 million gal./y ethanol facility in Indian River County, Florida with the intention of converting the current failed process into the company's patented CTS process under a sub-license from Alliance BioEnergy. Pending the completion of the plant negotiations and purchase, operations are expected to reach capacity in early 2018, potentially generating US$25 million in EBITDA and then will look to double capacity to 16 million gal./y, potentially generating US$54 million in EBITDA in 2019 before maximising capacity of 34 million gal./y, generating US$112 million in 2021.

The company's patented CTS process allows it to produce cellulosic ethanol for less than US$1/gal. and have 85 – 95% less greenhouse gases than petroleum-based products.

"We look forward to taking the next steps in solidifying our purchase of our own cellulosic ethanol production plant and believe the increased demand for cheaper biofuels will continue to drive growth of the company and the industry," said Jim Brown, President, Alliance Bio-Products, Inc. "This offering will be the first step of many to expand the company's capacity and enable a faster turnaround through the production of less expensive ethanol from local agricultural and yard waste. We believe the purchase of this plant will put our company in the best position possible to reach mass commercialisation of our product and to ultimately produce revenue and bring value back to shareholders."